MedPath

comparison of two antipsychotics Risperidone and olanzapine in their effectiveness and side effects in treatment of Bipolar Disorder

Phase 4
Conditions
Health Condition 1: null- patients clinically diagnosed to have bipolar affective disorder
Registration Number
CTRI/2014/07/004800
Lead Sponsor
Dr Manjuprasad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

(1) patients on above mentioned age groups and sex

(2)Patients on mood stabilizer Divalproaex sodium

Exclusion Criteria

(1)Age less than 18yrs and more than 65yrs.

(2)Serious medical disorders endangering life.

(3)Judged clinically to be at serious suicidal risk.

(4)Patients on mood stabilizer other than divalproaex sodium

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath